Last updated on October 2016

A study of rHIgM22 dosage in relapsing MS patients.


Brief description of study

A study of rHIgM22 dosage in relapsing MS patients.

Detailed Study Description

The purpose of this study is to measure safe and tolerable doses of rHIgM22 in patients with MS immediately following a relapse.

Clinical Study Identifier: TX145811

Find a site near you

Start Over

Collaborative Neuro Science Network

2600 Redondo Avenue, Suite 500 Long Beach, CA USA
  Connect »